Portfolio
MEDTECH & DEVICES | DIGITAL HEALTH
- High Fidelity Orthopaedics was created by Centralyze in 2021, the goal of which was to develop an AI-driven software analytics
platform together with advanced mechatronics to design and manufacture patient matched orthopaedic implants for emergency trauma instruments. - Cumulative revenue across all aspects of the business is $42m and we now have 15 staff employed in NSW.
MEDTECH & DEVICES | DIAGNOSTICS
- Equinox Medical was created by Centralyze in 2019, the goal of which was to introduced high-quality, low-cost medical devices across orthopaedic spine and pathology.
- Equinox pathology products are now in use across NSW and Australia
- Cumulative revenue across all aspects of the business is $42m and with15 staff currently employed in NSW.
THERAPEUTICS | DIAGNOSTICS
- Microba Life Sciences is a precision microbiome science company with a mission of improving human health.
- With world-leading technology for microbiome analysis, Microba is developing novel treatments and innovative testing solutions that harness the microbiome for better health outcomes.
- Established and funded a $25m Drug Development Pipeline, 5 international co-development partners
- Medical Affairs program DNA extraction, sequencing, secondary and tertiary analysis (bioinformatics)
- Probiotic Assessment, ISO15189 accreditation
ONCOLOGY
- US$10+ million invested in development of portfolio of clinical candidates for treatment of human respiratory viruses.
- Clearance for first in-human clinical trial of Viral Entry Inhibitor candidates, supported delivery of FDA IND application
- Lead development partners: Wuxi AppTec (Manufacturing, CRO, China), Charles River (Preclinical, CRO, US) and Kansas State University (in-field, animal studies, US).
- Created PRRS, antiviral and oncology Development Program, developed commercialisation strategy, Valuation Modelling, drafted and executed cross border licence agreement.